Inflammation and Recovery: A Double-Edged Sword
You need some inflammation to adapt. High-dose NSAIDs can blunt it. The nuance, explained.
Inflammation has a bad reputation in wellness culture, where it is often treated as a uniformly harmful thing to be suppressed at every opportunity. But when it comes to recovery and adaptation, that framing is not just incomplete — it can be actively counterproductive. The acute inflammatory response to exercise is part of how your body decides to get stronger. Blunt it indiscriminately, and you may blunt the very adaptation you trained for.
The signal you don’t want to silence
When you train hard, you create local stress and microdamage. The body responds with an acute inflammatory process: immune cells arrive, signaling molecules coordinate cleanup and repair, and this cascade carries the message that tells tissues to rebuild. The inflammation is not the injury; it is part of the response that turns the stimulus into a result.
The most direct human evidence that suppressing this can backfire comes from a 2018 randomized trial in Acta Physiologica (Lilja et al.). Healthy adults aged 18–35 took either a maximal over-the-counter dose of ibuprofen (1,200 mg/day) or a low dose of aspirin (75 mg/day) for 8 weeks of supervised resistance training.
Over 8 weeks, the high-dose ibuprofen group gained roughly half the muscle of the low-dose aspirin group: quadriceps volume rose 3.7% with ibuprofen versus 7.5% with aspirin (p = 0.029).
Strength on the conventional weight-stack training improved similarly across groups, so the cost was concentrated in muscle growth and some power measures rather than across the board. The dose matters: separate work has found that a moderate 400 mg/day of ibuprofen does not appear to hurt hypertrophy, and the picture for routine antioxidant megadoses is genuinely mixed. The principle is real, but it applies most clearly to high, chronic doses taken prophylactically — not the occasional pill.
Acute versus chronic — the distinction that matters
The double-edged nature comes from conflating two very different things:
- Acute inflammation: the short-lived, localized response to a specific stress like a workout. Part of repair and adaptation.
- Chronic, systemic inflammation: the persistent low-grade kind associated with poor sleep, excess body fat, and metabolic dysfunction. Genuinely harmful over time.
Reducing chronic inflammation is a worthy goal. Reflexively suppressing every acute inflammatory response is a different and often misguided one. They get lumped together under one word, which is the root of most confusion here.
What this means in practice
The reasonable posture is to support the body’s normal acute response rather than fight it. Use anti-inflammatory medications for genuine pain or injury when appropriate, not as a daily prophylactic around every session, and don’t assume more suppression is always better. The high-dose, long-term use studied by Lilja is the pattern most clearly linked to blunted gains. Meanwhile, address the lifestyle drivers of chronic inflammation — sleep, body composition, stress — which is where the real long-term payoff lives.
The takeaway
Inflammation is not a single villain to be minimized at all costs. Acute, training-induced inflammation is part of how adaptation happens, and there is human trial evidence that high-dose ibuprofen taken daily can roughly halve hypertrophy gains over two months. Chronic systemic inflammation is the kind genuinely worth reducing. The skill is telling them apart — and resisting the tidy but wrong instinct that less inflammation is always better.